A Double Blind Study in Pediatric Subjects With Chronic Plaque Psoriasis, Studying Adalimumab vs. Methotrexate
Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
This study will compare how well adalimumab works versus methotrexate (MTX) in children with
moderate to severe psoriasis in the short term. It will also study how safe and how well
adalimumab works in the long term and how long disease response can be maintained after
stopping therapy.